Cell Signaling in Cancer: New Targets, New Hope

The Scientist is bringing together a panel of experts to discuss their research and share insights into targeting these pathways with anti-cancer therapeutics.

By The Scientist Creative Services Team | June 1, 2017

 

FREE Webinar

Thursday, June 1, 2017
2:30 - 4:00 P.M. EDT
Register Now

Communication between cancer cells has long been a target of drug-discovery efforts, but the conversations between cells can be convoluted and confused by signaling-pathway crosstalk, feedback loops, and other complex interactions. Recent advances have led to the elucidation of unexpected interactions between cells during the oncogenic transition, and these interactions are specific to the tumor microenvironment. To explore the advances in understanding cancer signaling, The Scientist is bringing together a panel of experts to discuss their research and share insights into targeting these pathways with anti-cancer therapeutics. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics related to their research.

Topics to be covered:

  • How the tumor microenvironment shapes tumor behavior and therapeutic efficacy
  • Signaling-pathway manipulation as a key strategy for anticancer therapies

Register Now

Meet the Speakers:

Lynne-Marie Postovit, PhD
Associate Professor, Department of Experimental Oncology
University of Alberta

 

 

 

 

William Weiss, MD, PhD
Professor, Departments of Neurology, Pediatrics, and Neurosurgery
University of California, San Francisco

 

 


 

Rockland
BioLegend
Mettler Toledo
R&D Systems

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Two University of Rochester Professors Resign in Protest
  2. Dartmouth Professor Investigated for Sexual Misconduct Retires
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Koko the Signing Gorilla Dies at 46